[The lazy eye - contemporary strategies of amblyopia treatment].

Amblyopia is a condition of decreased monocular or binocular visual acuity caused by form deprivation or abnormal binocular interaction. Amblyopia is the most common cause of monocular vision loss in children with a prevalence of 2 to 5%. During the last decade, several prospective randomized studies have influenced our clinical management. Based on these studies, optimum refractive correction should be prescribed first. However, most patients will need additional occlusion therapy which is still considered the «gold standard» of amblyopia management. Now much lower doses have been shown to be effective. In moderate amblyopia, penalization with atropine is as effective as patching. New treatment modalities including perceptual learning, pharmacotherapy with levodopa and citicholine or transcranial magnetic stimulation have not yet been widely accepted.
AuthorsV Sturm
JournalPraxis (Praxis (Bern 1994)) Vol. 100 Issue 4 Pg. 229-35 (Feb 16 2011) ISSN: 1661-8157 [Print] Switzerland
Vernacular Title«The Lazy Eye» - Aktuelle Strategien der Amblyopiebehandlung.
PMID21328237 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Mydriatics
  • Atropine
  • Age Factors
  • Amblyopia (diagnosis, drug therapy, epidemiology, therapy)
  • Atropine (administration & dosage, therapeutic use)
  • Child
  • Depth Perception
  • Humans
  • Mydriatics (administration & dosage, therapeutic use)
  • Prevalence
  • Refraction, Ocular
  • Vision Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: